EDGM · Edgemode, Inc. · Insider Trading

The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

Common Stock issued pursuant to the March 23, 2026 Addendum No. 2 (the "Addendum") to the Joint Venture Agreement by and among the Issuer, Blackberry, AIF and DC Estate Solutions Cayman Limited dated January 22, 2026, as amended (the "JVA"), and in exchange for terminating stock options in a transaction that was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the board of directors of the Issuer.

Common Stock held by EMM International Investment Ltd, an entity beneficially owned and controlled by the Reporting Person, Jose Antonio Mora.

The stock options shall automatically become vested and exercisable as follows: 50% shall vest upon the closing of purchase agreement between the Company, or the Company's subsidiaries, and a solid oxide fuel cell supplier for a minimum power capacity of 100 MW, as determined by the Company's board of directors (the "Board"), and the remaining 50% shall become vested and exercisable upon the closing of an AI data center site sale agreement between the Company, or the Company's subsidiaries, and a buyer which is for a minimum capacity of 100 MW, as determined by the Board.

The stock options shall automatically become vested and exercisable as follows: 50% shall vest upon the closing of purchase agreement between the Company, or the Company's subsidiaries, and a solid oxide fuel cell supplier for a minimum power capacity of 100 MW, as determined by the Company's board of directors (the "Board"), and the remaining 50% shall become vested and exercisable upon the closing of an AI data center site sale agreement between the Company, or the Company's subsidiaries, and a buyer which is for a minimum capacity of 100 MW, as determined by the Board.

The non-qualified stock options are fully vested.

The non-qualified stock options shall expire the earlier of (i) January 27, 2031 or (ii) the termination of the Joint Venture Agreement dated January 22, 2026 by and between Blackberry AIF and the DC Estate Solutions Cayman Limited, as amended.

Stock Options held by EMM International Investment ltd, an entity beneficially owned and controlled by the Reporting Person.

The Reporting Person agreed to terminate stock options pursuant to the Addendum No.2, dated March 23, 2026, to the JVA in exchange for the issuance of 400,000,000 shares of common stock, as reported in Table I. Such transaction was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3, as it was approved in advance by the board of directors of the Issuer.

The stock options were to expire the earlier of (i) January 27, 2031 or (ii) the termination of the JVA.

Non-qualified stock options held by EMM International Investment Ltd, an entity beneficially owned and controlled by the Reporting Person, Jose Antonio Mora.

The Reporting Person agreed to terminate stock options pursuant to the Addendum No.2, dated March 23, 2026, to the JVA in exchange for the issuance of 400,000,000 shares of common stock, as reported in Table I. Such transaction was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3, as it was approved in advance by the board of directors of the Issuer.

The stock options were to expire the earlier of (i) January 22, 2031 or (ii) the termination of the JVA.

Non-qualified stock options held by EMM International Investment Ltd, an entity beneficially owned and controlled by the Reporting Person, Jose Antonio Mora.

The Series D Preferred Stock is not convertible, does not have any redemption, preferential dividend or liquidation rights.

The Reporting Person converted $386,000 of accrued salary under that certain Employment Agreement dated January 31, 2022, as amended, and acquired one share of Series D Preferred Stock.

The Series D Preferred Stock is perpetual and therefore has no expiration date.

Holder of Series D Preferred Stock shall be entitled to vote with the holders of common stock on all matters submitted to a vote of shareholders and each share of Series D Preferred Stock entitles the holder to voting power equal to 25.5% of the issued and outstanding shares of the Issuer's common stock.

The Series D Preferred Stock is not convertible, does not have any redemption, preferential dividend or liquidation rights.

The Reporting Person converted $386,000 of accrued salary under that certain Employment Agreement dated January 31, 2022, as amended, and acquired one share of Series D Preferred Stock.

The Series D Preferred Stock is perpetual and therefore has no expiration date.

Holder of Series D Preferred Stock shall be entitled to vote with the holders of common stock on all matters submitted to a vote of shareholders and each share of Series D Preferred Stock entitles the holder to voting power equal to 25.5% of the issued and outstanding shares of the Issuer's common stock.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

The Reporting Person cashlessly exercised stock options and acquired shares of the Issuer's common stock, which was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

The Reporting Person cashlessly exercised stock options and acquired shares of the Issuer's common stock, which was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

The Reporting Person cashlessly exercised stock options and acquired shares of the Issuer's common stock, which was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

Includes 54,354,099 shares of common stock held by the Reporting Person's wife.

The Reporting Person cashlessly exercised stock options and acquired shares of the Issuer's common stock, which was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

Not applicable.

The stock options are fully vested and exercisable.

Not applicable.

The stock options are fully vested and exercisable.

The shares of common stock were issued pursuant to the Share Exchange Agreement dated April 7, 2025, by and among the Issuer, Synthesis Analytics Production Ltd. and Adler Capital Limited.

The Reporting Person is the beneficial owner and sole officer and director with voting and dispositive control of Adler Capital Limited.

Not applicable.

The stock options are fully vested and exercisable.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The reported transactions involved amendments of outstanding stock options, resulting in the cancellation of the "original" stock option and the grant of a replacement stock option. The original stock options have been amended to reduce the exercise price per share to $0.005 per share in exchange for reducing the Reporting Person's accrued salary by $50,0000. The rest of the terms of the original stock options remain in full force and effect.

The Series C Preferred Stock is not convertible, does not have any redemption, preferential dividend or liquidation rights. Any Series C Preferred Stock issued and outstanding on the record date to vote and/or consent to an approval of an amendment to the Company's Articles of Incorporation authorizing an increase in the Company's authorized capital (the "Charter Amendment") shall be automatically surrendered and cancelled for no consideration following the Charter Amendment.

Holder of Series C Preferred Stock shall only be entitled to vote on the approval Charter Amendment and shall be entitled to a voting power equal to one vote more than the total combined voting power of the Company's common stock.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

The Reporting Person was granted with the shares of restricted common stock as partial consideration to convert $769,989 of accrued salary under the Reporting Person's Employment Agreement with the Issuer.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

The Reporting Person was granted with the shares of restricted common stock as partial consideration to convert $769,989 of accrued salary under the Reporting Person's Employment Agreement with the Issuer.

Not applicable.

The two reported transactions involved an amendment of an outstanding stock option, resulting in the cancellation of the "old" stock option and the grant of a replacement stock option. The original stock options granted have been amended and restated to become vested and exercisable immediately. The rest of the terms of the original stock options remain in full force and effect.

Not applicable.

The stock options shall vest upon the Issuer closing on the purchase of at least $15 million of crypto mining equipment.

Not applicable.

The stock options shall vest upon the Issuer closing on the purchase of at least $15 million of crypto mining equipment.